Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
49
BLTE Quote, Financials, Valuation and Earnings
Last price:
$178.12
Seasonality move
:
-6.19%
Day range:
$173.32 - $188.75
52-week range:
$49.00 - $200.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
24.31x
Volume:
423.9K
Avg. volume:
207.3K
1-year change:
210.45%
Market cap:
$6.7B
Revenue:
--
EPS (TTM):
-$1.92
Earnings Data
Next earnings date for BLTE
--
Most recent earnings per share
-$0.65
Missed by $0.16
(Nov 10/2025)
Consensus Estimate
-$0.49
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BLTE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.57 | -- |
| 03/02/2026 | Q4 | -- | -- | -- | -$0.54 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.65 | -$0.49 | -$0.16 |
| 08/11/2025 | Q2 | -- | -- | -$0.50 | -$0.42 | -$0.08 |
| 05/12/2025 | Q1 | -- | -- | -$0.45 | -$0.37 | -$0.08 |
| 03/17/2025 | Q4 | -- | -- | -$0.32 | -$0.31 | -$0.01 |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.30 | $0.02 |
| 08/12/2024 | Q2 | -- | -- | -$0.31 | -$0.26 | -$0.05 |
| 05/14/2024 | Q1 | -- | -- | -$0.27 | -$0.29 | $0.02 |
| 03/12/2024 | Q4 | -- | -- | -$0.25 | -$0.30 | $0.05 |
| 11/14/2023 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/09/2023 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/10/2023 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/31/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 12/15/2022 | Q3 | -- | -- | -$0.10 | -- | -- |
| 08/10/2022 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.04 | -- | -- |
Belite Bio, Inc. Earnings Questions
-
How Much did Belite Bio, Inc. Generate in Revenue Last Quarter?
Belite Bio, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Belite Bio, Inc. Beat Earnings Last Quarter?
Belite Bio, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.49 per share.
-
Is Belite Bio, Inc. Profitable?
Belite Bio, Inc. reported -$347K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Belite Bio, Inc. EPS Next Year?
Belite Bio, Inc.'s earnings are forecast to decrease from -$1.18 per share to -$2.18 per share next year representing a decrease of -1.14%.
-
When is Belite Bio, Inc.'s Earnings Date?
Currently, Belite Bio, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
50
AXTI alert for Mar 3
AXT, Inc. [AXTI] is up 22.11% over the past day.
Buy
53
AAOI alert for Mar 3
Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.
Sell
32
TPB alert for Mar 3
Turning Point Brands, Inc. [TPB] is down 20.87% over the past day.
